General - Laatste dingen 1 Flashcards
(84 cards)
1
Q
ERU
a. GYS-1
b. TRPM1
c. RYR1
d. GBE1
A
b. TRPM1
2
Q
timolol
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer
A
a. B adrenerge receptor blocker
3
Q
dorzolamide
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer
A
B. koolzuuranhydrase remmer
3
Q
Leptin in obese donkeys
a. higher
b. lower
A
a. higher
3
Q
Type A lactic acidosis
a. hypoxia
b. abscence of hypoxemia
A
a. hypoxia
3
Q
Leptin in old donkeys
a. higher
b. lower
A
a. higher
3
Q
Type B lactic acidosis
a. hypoxia
b. abscence of hypoxemia
A
b. abscence of hypoxemia
4
Q
Dobutamine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist
A
a. B1 agonist
5
Q
Norepinephrine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist
A
c. a1 agonist
6
Q
Epineephrine
a. a
b. b
c. a en b
A
c. a en b
7
Q
Phenylefrine
a. a
b. b
c. a en b
A
a. a
8
Q
Lower PCO2
a. left shift
b. right shift
A
a. left shift
9
Q
Lower [H+]
a. left shift
b. right shift
A
a. left shift
10
Q
Higher temp
a. left shift
b. right shift
A
b. right shift
11
Q
Higher DPG
a. left shift
b. right shift
A
b. right shift
12
Q
Lower [PO4,3-]
a. left shift
b. right shift
A
a. left shift
13
Q
Lower pH
a. left shift
b. right shift
A
b. right shift
14
Q
Higher pH
a. left shift
b. right shift
A
a. left shift
15
Q
Hydrophobic / low surface tension
a. SP-B and SP-C
b. SP-A and SP-D
A
a. SP-B and SP-C
16
Q
Hydrophilic / antimicrobial
a. SP-B and SP-C
b. SP-A and SP-D
A
b. SP-A and SP-D
17
Q
Medial compartment
a. IX, XI, XII
b. V, VII, VIII
A
a. IX, XI, XII
18
Q
Lateral compartment
a. IX, XI, XII
b. V, VII, VIII
A
b. V, VII, VIII
19
Q
African horse sickness
a. Culicoides imicola (biting midge)
A
a. Culicoides imicola (biting midge)
20
Q
EIV
a. RNA
b. DNA
A
a. RNA
21
EHV
a. RNA
b. DNA
b. DNA
22
MH
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
a. RYR1
23
PSSM
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
b. GYS-1
24
GBED
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
d. GBE1
25
HYPP
a. RYR1
b. SCN4A
c. GYS-1
d. TRPM1
b. SCN4A
26
Excitatory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine
a. glutamate, aspartate and acetylcholine
27
Inhibitory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine
b. GABA, glycine, taurine, norepinephrine
28
Type 1 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)
b. insulin dependent (lack of insulin)
29
Type 2 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)
a. non-insulin dependent (tissue sensitivity impaired)
30
Congential agangliosis
a. RYR1
b. SCN4A
c. EDNRB
d. TRPM1
c. EDNRB
31
Zone 1
a. periportal
b. centrolubular
a. periportal
32
Zone 3
a. periportal
b. centrolubular
b. centrolubular > KLOPT DIT?
33
Highest p450 mixed function oxidase
a. Zone 1
b. Zone 2
c. Zone 3
c. Zone 3
34
Highest p450 mixed function oxidase
a. periportal
b. centrolubular
b. centrolubular > KLOPT DIT?
35
Insulin vs. lipoprotein lipase
a. stimulation
b. inhibition
a. stimulation
36
Glucocorticoids vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
37
Growth hormone vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
38
Azotemia vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
39
Insulin vs. hormone sensitive lipase
a. stimulation
b. inhibition
b. inhibition
40
Glucocorticoids vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulation
41
Growth hormone vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulation
42
Azotemia vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulationI
43
Insulin vs. gluconeogenesis
a. stimulation
b. inhibition
b. inhibition
44
Glucocorticoids vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
45
Glucagon vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
46
Catecholamines vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
47
Insulin vs. glycogenolysis
a. stimulation
b. inhibition
b. inhibition
48
Glucocorticoids vs. glycogenolysis
a. stimulation
b. inhibition
a. stimulation
49
Glucagon vs. glycogenolysis
a. stimulation
b. inhibition
a. stimulation
50
Insulin vs. fatty acid synthesis in liver
a. stimulation
b. inhibition
a. stimulation
51
Phase 1
a. oxygenation
b. conjugation
a. oxygenation
52
Phase 1
a. hydroxylation
b. conjugation
a. hydroxylation
53
Phase 1
a. deamination
b. conjugation
a. deamination
54
Phase 1
a. reduction
b. conjugation
a. reduction
55
Phase 2
a. hydroxylation
b. conjugation
c. deamination
d. reduction
b. conjugation
55
Centrilobular zonal injury
a. zone 1
b. zone 2
c. zone 3
c. zone 3
56
Periacinar (paracentral)
a. zone 1
b. zone 2
c. zone 3
c. zone 3
56
Compensatory pause
a. APCs
b. VPCs
b. VPCs
57
Acinuar lobular injury
a. zone 1
b. zone 2
c. zone 3
a. zone 1
57
Periportal injury
a. zone 1
b. zone 2
c. zone 3
a. zone 1
58
Conjugated <25%
a. hepatocellular disease
b. cholestasis
a. hepatocellular disease
58
Vitamine K dependent factors
a. III, IV, VIII, protein C
b. II, IV, XI, XII, protein C
c. IV, VI, IX, XI, protein C
d. II, VII, IX, X protein C
d. II, VII, IX, X and protein C
58
Volume overload receiving chamber VSD
a. LA and LV
b. RA and RV
a. LA and LV
58
Conjugated >30%
a. hepatocellular disease
b. cholestasis
b. cholestasis
58
Which valve has 2 cups?
a. tricuspid
b. mitral
c. pulomary
d. aorta
b. mitral
58
Volume overload receiving chamber PDA
a. LA and LV
b. RA and RV
a. LA and LV
58
Eccentric hypertrophy
a. endurance-trained
b. resistance trainend
a. endurance-trained
58
Concentric hypertrophy
a. endurance-trained
b. resistance trainend
b. resistance trainend
58
Volume overload receiving chamber ASD
a. LA and LV
b. RA and RV
b. RA and RV
58
S1
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction
a. atrioventricular valve closure
58
S2
a. rapid ventricular filling
b. atrial contraction
c. semilunar valve closure
d. atrioventricular valve closure
b. semilunar valve closure
58
S4
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction
d. atrial contraction
58
S3
a. rapid ventricular filling
b. semilunar valve closure
c. atrioventricular valve closure
d. atrial contraction
a. rapid ventricular filling
59
Non-compensatory pause
a. APCs
b. VPCs
a. APCs
60
PT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
61
aPTT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
62
A1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
a. no cutaenous involvement
63
A2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
b. no cutaenous involvement but locally invasive
64
B1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
c. overlying skin cannot be moved over nodule, no deep tissue invasion
65
B2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
d. overlying skin cannot be moved over nodule, attached to deeper tissues
